XML 85 R69.htm IDEA: XBRL DOCUMENT v3.10.0.1
SHARE-BASED COMPENSATION PLANS (Details) - USD ($)
12 Months Ended
Feb. 22, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2018
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of shares available for future grant (in shares)         7,075,015  
Compensation cost charged to expense under all share-based incentive awards [Abstract]            
Total compensation cost   $ 24,000,000 $ 29,000,000 $ 34,600,000    
Unrecognized compensation cost related to nonvested share-based compensation arrangements         $ 28,200,000  
Compensation expense over a remaining weighted-average period   1 year 7 months 12 days        
Weighted-average grant-date fair value per share            
Nonvested at end of period (in dollars per share) $ 7.04          
Weighted-average exercise price            
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term 5 years 6 months          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 1.987%          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 40.551%          
Nonvested at end of period (in dollars per share) $ 7.04          
Minimum [Member]            
Weighted-average grant-date fair value per share            
Requisite service period   6 months        
Non Employee Director Non-Deferred Restricted Share Units [Member]            
Number of Shares            
Outstanding, beginning of period (in shares)   91,000        
Granted (in shares)   78,000        
Vested / Settled (in shares)   (91,000)        
Outstanding, end of period (in shares)   78,000 91,000      
Vested at end of period (in shares)   0        
Weighted-average grant-date fair value per share            
Outstanding, beginning of period (in dollars per share)   $ 13.24        
Granted (in dollars per share)   15.29 $ 13.24      
Vested / Settled (in dollars per share)   13.24        
Outstanding, end of period (in dollars per share)   15.29 13.24      
Vested at end of period (in dollars per share)   $ 0.00        
Fair value of shares of common stock issued in connection with settlement of vested RSUs   $ 1,400,000        
Granted (in dollars per share)   $ 15.29 $ 13.24      
Restricted Shares And Restricted Share Units [Member]            
Compensation cost charged to expense under all share-based incentive awards [Abstract]            
Total compensation cost   $ 18,000,000 $ 19,300,000 21,800,000    
Restricted Shares And Restricted Share Units [Member] | Maximum [Member]            
Weighted-average grant-date fair value per share            
Requisite service period   36 months        
Share appreciation rights [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting percentage   33.33%        
Compensation cost charged to expense under all share-based incentive awards [Abstract]            
Total compensation cost   $ 0 $ 0 $ 200,000    
Awards vesting period   3 years        
Weighted-average grant-date fair value per share            
Expiration period   10 years        
Number of shares under SARs            
Outstanding at beginning of period (in shares)   1,029,000        
Exercised (in shares)   0 0 0    
Forfeited or expired (in shares)   (17,000)        
Outstanding at end of period (in shares)   1,012,000 1,029,000      
Grants (in shares)   0 0 0    
Number of shares under SARs exercisable         1,012,000  
Weighted-average exercise price            
Outstanding at beginning of period (in dollars per share)   $ 31.03        
Forfeited or expired (in dollars per share)   36.86        
Outstanding at end of period (in dollars per share)   $ 30.93 $ 31.03      
Exercisable at end of period (in dollars per share)         $ 30.93  
Outstanding at end of period, Weighted-average remaining contractual term (in years)   2 years 8 days        
Exercisable at end of period, Weighted-average remaining contractual term (in years)   2 years 8 days        
Outstanding at end of period, Aggregate intrinsic value         $ 0  
Exercisable at end of period, Aggregate intrinsic value         $ 0  
Share options [Member]            
Number of shares under SARs            
Outstanding at beginning of period (in shares)   455,000        
Exercised (in shares)   (5,000) 0 0    
Forfeited or expired (in shares)   (95,000)        
Outstanding at end of period (in shares)   355,000 455,000      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number         0  
Weighted-average exercise price            
Outstanding at beginning of period (in dollars per share)   $ 17.08        
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price   15.31        
Forfeited or expired (in dollars per share)   15.31        
Outstanding at end of period (in dollars per share)   $ 17.59 $ 17.08      
Exercisable at end of period (in dollars per share)         $ 0.00  
Outstanding at end of period, Weighted-average remaining contractual term (in years)   5 years 1 month 23 days        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value   $ 19,200        
Outstanding at end of period, Aggregate intrinsic value         $ 0  
Exercisable at end of period, Aggregate intrinsic value         $ 0  
Share options [Member] | Minimum [Member]            
Weighted-average grant-date fair value per share            
Requisite service period   3 years        
Expiration period   7 years        
Restricted shares [Member]            
Number of Shares            
Nonvested at beginning of period (in shares)   0        
Granted (in shares)   367,000 0      
Vested / Settled (in shares)   (141,000)        
Nonvested at end of period (in shares)   226,000 0      
Weighted-average grant-date fair value per share            
Nonvested at beginning of period (in dollars per share)   $ 0.00        
Granted (in dollars per share)   14.99 $ 18.60      
Vested / Settled (in dollars per share)   15.18        
Nonvested at end of period (in dollars per share)   $ 14.88 $ 0.00      
Fair value of shares vested   $ 1,300,000 $ 758,000 $ 37,000    
Granted (in dollars per share)   $ 14.99 $ 18.60      
Weighted-average exercise price            
Nonvested at end of period (in dollars per share)   $ 0.00 $ 0.00   $ 14.88 $ 0.00
Restricted share units (RSUs) [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Award vesting percentage   33.33%        
Number of Shares            
Nonvested at beginning of period (in shares)   2,436,000        
Granted (in shares)   1,334,000        
Vested / Settled (in shares)   (1,004,000)        
Forfeited (in shares)   (193,000)        
Cancelled (in shares)   (367,000)        
Nonvested at end of period (in shares)   2,206,000 2,436,000      
Weighted-average grant-date fair value per share            
Nonvested at beginning of period (in dollars per share)   $ 15.59        
Granted (in dollars per share)   13.60 $ 17.09 $ 11.62    
Vested / Settled (in dollars per share)   15.44        
Forfeited (in dollars per share)   14.32        
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Cancelled, Weighted Average Grant Date Fair Value   14.99        
Nonvested at end of period (in dollars per share)   $ 14.67 $ 15.59      
Fair value of shares vested   $ 13,700,000 $ 17,800,000 $ 14,600,000    
Requisite service period   3 years        
Granted (in dollars per share)   $ 13.60 $ 17.09 $ 11.62    
Weighted-average exercise price            
Nonvested at end of period (in dollars per share)   $ 15.59 $ 15.59   $ 14.67 $ 15.59
Non Employee Director Deferred Restricted Share Units [Member]            
Number of Shares            
Outstanding, beginning of period (in shares)   203,000        
Granted (in shares)   26,000        
Vested / Settled (in shares)   0 (114,000) (54,000)    
Outstanding, end of period (in shares)   229,000 203,000      
Vested at end of period (in shares)   203,000        
Weighted-average grant-date fair value per share            
Outstanding, beginning of period (in dollars per share)   $ 25.62        
Granted (in dollars per share)   15.29 $ 13.24 $ 17.43    
Vested / Settled (in dollars per share)   0.00        
Outstanding, end of period (in dollars per share)   24.44 $ 25.62      
Vested at end of period (in dollars per share)   25.62        
Fair value of shares of common stock issued in connection with settlement of vested RSUs     $ 1,500,000 $ 1,000,000    
Granted (in dollars per share)   $ 15.29 $ 13.24 $ 17.43    
Non Employee Director Deferred and Non-Deferred Restricted Share Units [Member]            
Weighted-average grant-date fair value per share            
Fair value of long-term liabilities         $ 2,300,000 $ 3,800,000
Performance Shares [Member]            
Compensation cost charged to expense under all share-based incentive awards [Abstract]            
Total compensation cost   $ 6,000,000 $ 9,700,000 $ 12,600,000    
Weighted-average grant-date fair value per share            
Performance-based awards, target value, per share amount   $ 100 $ 100 $ 100    
Cash paid for units vested   $ 11,900,000 $ 11,400,000 $ 7,900,000    
Weighted-average exercise price            
Share-Based Compensation Arrangement By Share-Based Payment Award Equity Instruments Other Than Options, Aggregate Grant Date Fair Value1       $ 8,600,000 7,000,000 9,500,000
Performance Shares [Member] | Maximum [Member]            
Compensation cost charged to expense under all share-based incentive awards [Abstract]            
Awards vesting period   36 months        
Other Current Liabilities [Member] | Performance Shares [Member]            
Compensation cost charged to expense under all share-based incentive awards [Abstract]            
Deferred Compensation Share-based Arrangements, Liability, Current         9,100,000 11,500,000
Other Liabilities [Member] | Performance Shares [Member]            
Compensation cost charged to expense under all share-based incentive awards [Abstract]            
Deferred Compensation Share-based Arrangements, Liability, Current         $ 7,000,000 $ 10,500,000
February 27, 2018 Grant [Member] | Performance Shares [Member]            
Compensation cost charged to expense under all share-based incentive awards [Abstract]            
Awards vesting period   3 years        
February 27, 2018 Grant [Member] | Performance Shares [Member] | Minimum [Member]            
Compensation cost charged to expense under all share-based incentive awards [Abstract]            
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected Per Share Amount         $ 0  
February 27, 2018 Grant [Member] | Performance Shares [Member] | Maximum [Member]            
Compensation cost charged to expense under all share-based incentive awards [Abstract]            
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected Per Share Amount         200  
Granted in 2017 and 2016 [Member] | Performance Shares [Member]            
Compensation cost charged to expense under all share-based incentive awards [Abstract]            
Awards vesting period   3 years        
Granted in 2017 and 2016 [Member] | Performance Shares [Member] | Minimum [Member]            
Compensation cost charged to expense under all share-based incentive awards [Abstract]            
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected Per Share Amount         0  
Granted in 2017 and 2016 [Member] | Performance Shares [Member] | Maximum [Member]            
Compensation cost charged to expense under all share-based incentive awards [Abstract]            
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Expected Per Share Amount         $ 200  
Granted During 2017 [Member] | Share options [Member]            
Weighted-average grant-date fair value per share            
Requisite service period   4 years        
Share-based Compensation Award, Tranche One [Member] | February 27, 2018 Grant [Member] | Performance Shares [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Unit Value Determined On Annual Performance   25.00%        
Weighted-average exercise price            
Share-based Compensation Arrangement by Share-based Payment Award, Period For Value Determination   1 year        
Share-based Compensation Award, Tranche One [Member] | Granted in 2017 and 2016 [Member] | Performance Shares [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Unit Value Determined On Annual Performance   25.00%        
Weighted-average exercise price            
Share-based Compensation Arrangement by Share-based Payment Award, Period For Value Determination   1 year        
Share-based Compensation Award, Total Period [Member] | February 27, 2018 Grant [Member] | Performance Shares [Member]            
Weighted-average exercise price            
Share-based Compensation Arrangement by Share-based Payment Award, Period For Value Determination   3 years        
Share-based Compensation Arrangement by Share-based Payment Award, Performance Unit Value Determined On Total Vesting Period Performance   25.00%        
Share-based Compensation Award, Total Period [Member] | Granted in 2017 and 2016 [Member] | Performance Shares [Member]            
Weighted-average exercise price            
Share-based Compensation Arrangement by Share-based Payment Award, Period For Value Determination   3 years        
Share-based Compensation Arrangement by Share-based Payment Award, Performance Unit Value Determined On Total Vesting Period Performance   25.00%        
Share-based Compensation Award, Tranche Two [Member] | February 27, 2018 Grant [Member] | Performance Shares [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Unit Value Determined On Annual Performance   25.00%        
Weighted-average exercise price            
Share-based Compensation Arrangement by Share-based Payment Award, Period For Value Determination   1 year        
Share-based Compensation Award, Tranche Two [Member] | Granted in 2017 and 2016 [Member] | Performance Shares [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Unit Value Determined On Annual Performance   25.00%        
Weighted-average exercise price            
Share-based Compensation Arrangement by Share-based Payment Award, Period For Value Determination   1 year        
Share-based Compensation Award, Tranche Three [Member] | February 27, 2018 Grant [Member] | Performance Shares [Member]            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Performance Unit Value Determined On Annual Performance   25.00%        
Weighted-average exercise price            
Share-based Compensation Arrangement by Share-based Payment Award, Period For Value Determination   1 year